Skip to main content
. 2020 Sep 9;12(9):858. doi: 10.3390/pharmaceutics12090858

Table 3.

In vitro cytotoxicity (CC50) of free BER, PC:Chol:TS, PC:Chol:DDAB, PC:Chol:DP liposomes or amphotericin B (AmB) in bone marrow-derived macrophages (BMDM) after 48-h treatment.

Drug BMDM CC50 (μM)
BER 125.3 ± 18.4
PC:Chol:TS-BER >1000
PC:Chol:DDAB-BER >1000
PC:Chol:DP-BER 140.2 ± 1.6
AmB 4.5 ± 1.2